Home/Filings/4/0001179110-15-002168
4//SEC Filing

Theravance Biopharma, Inc. 4

Accession 0001179110-15-002168

$TBPHCIK 0001583107operating

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 7:24 PM ET

Size

4.9 KB

Accession

0001179110-15-002168

Insider Transaction Report

Form 4
Period: 2015-02-05
BLUM LEONARD M
Sr VP, Chief Comm. Officer
Transactions
  • Award

    Ordinary Shares

    2015-02-05+90,000208,473 total
Footnotes (1)
  • [F1]Includes 18,038 shares acquired in a pro rata distribution by Theravance, Inc. which relate to a performance stock award granted by Theravance, Inc. on February 11, 2011, for which the performance conditions were achieved on February 5, 2015 (and which will vest on February 20, 2016, subject to the reporting person's continued employment through such date).

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeoperating
IncorporatedCA

Related Parties

1
  • filerCIK 0001583107

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 7:24 PM ET
Size
4.9 KB